SCOPUS 정보 검색 플랫폼

Expert Review of Proteomics

Volumn 7, Issue 6, 2010, Pages 819-821

PI3K-based molecular signatures link high PI3K pathway activity with low ER levels in ER+ breast cancer

(2) Sanchez, Alex a,b Villanueva, Josep c

a UNIVERSITY OF BARCELONA (Spain)

b Institut de Recerca (Spain)

c Hospital Vall DHebron (Spain)

Author keywords

breast cancer; endocrine resistance; hormone therapy; molecular signatures; PI3K pathway; signature scoring

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; GROWTH FACTOR RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; TAMOXIFEN;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER HORMONE THERAPY; CANCER RESISTANCE; ENZYME ACTIVITY; HUMAN; PROTEOMICS; SIGNAL TRANSDUCTION; TRANSCRIPTOMICS;

EID: 78650456605 PISSN: 14789450 EISSN: 17448387 Source Type: Journal
DOI: 10.1586/epr.10.103 Document Type: Article

Times cited : (2)

References (9)

1
- 69249137029
- Biological determinants of endocrine resistance in breast cancer
- Musgrove EA, Sutherland RL. Biological determinants of endocrine resistance in breast cancer. Nat. Rev. Cancer 9(9), 631-643 (2009).
- (2009) Nat. Rev. Cancer , vol.9 , Issue.9 , pp. 631-643
- Musgrove, E.A.¹ Sutherland, R.L.²

2
- 51149092061
- The role of hormonal therapy in the management of hormonal-receptor- positive breast cancer with co-expression of HER2
- Prat A, Baselga J. The role of hormonal therapy in the management of hormonal-receptor-positive breast cancer with co-expression of HER2. Nat. Clin. Pract. Oncol. 5(9), 531-542 (2008).
- (2008) Nat. Clin. Pract. Oncol. , vol.5 , Issue.9 , pp. 531-542
- Prat, A.¹ Baselga, J.²

3
- 77954974573
- Hyperactivation of phosphatidylinositol-3 kinase promotes escape from hormone dependence in estrogen receptor-positive human breast cancer
- Miller TW, Hennessy BT, Gonzalez- Angulo AM et al. Hyperactivation of phosphatidylinositol-3 kinase promotes escape from hormone dependence in estrogen receptor-positive human breast cancer. J. Clin. Invest. 120(7), 2406-2413 (2010).
- (2010) J. Clin. Invest. , vol.120 , Issue.7 , pp. 2406-2413
- Miller, T.W.¹ Hennessy, B.T.² Gonzalez-Angulo, A.M.³

4
- 31144459985
- Oncogenic pathway signatures in human cancers as a guide to targeted therapies
- DOI 10.1038/nature04296, PII NATURE04296
- Bild AH, Yao G, Chang JT et al. Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 439(7074), 353-357 (2006). (Pubitemid 43128862)
- (2006) Nature , vol.439 , Issue.7074 , pp. 353-357
- Bild, A.H.¹ Yao, G.² Chang, J.T.³ Wang, Q.⁴ Potti, A.⁵ Chasse, D.⁶ Joshi, M.-B.⁷ Harpole, D.⁸ Lancaster, J.M.⁹ Berchuck, A.¹⁰ Olson Jr., J.A.¹¹ Marks, J.R.¹² Dressman, H.K.¹³ West, M.¹⁴ Nevins, J.R.¹⁵

5
- 78149473552
- Proteomic and transcriptomic profiling reveals a link between the PI3K pathway and lower estrogen-receptor (ER) levels and activity in ER+ breast cancer
- Creighton C, Fu X, Hennessy BT et al. Proteomic and transcriptomic profiling reveals a link between the PI3K pathway and lower estrogen-receptor (ER) levels and activity in ER+ breast cancer. Breast Cancer Res. 12, R40 (2010).
- (2010) Breast Cancer Res. , vol.12
- Creighton, C.¹ Fu, X.² Hennessy, B.T.³

6
- 33749335282
- The connectivity map: Using gene-expression signatures to connect small molecules, genes, and disease
- DOI 10.1126/science.1132939
- Lamb J, Crawford ED, Peck D et al. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science 313(5795), 1929-1935 (2006). (Pubitemid 44497995)
- (2006) Science , vol.313 , Issue.5795 , pp. 1929-1935
- Lamb, J.¹ Crawford, E.D.² Peck, D.³ Modell, J.W.⁴ Blat, I.C.⁵ Wrobel, M.J.⁶ Lerner, J.⁷ Brunet, J.-P.⁸ Subramanian, A.⁹ Ross, K.N.¹⁰ Reich, M.¹¹ Hieronymus, H.¹² Wei, G.¹³ Armstrong, S.A.¹⁴ Haggarty, S.J.¹⁵ Clemons, P.A.¹⁶ Wei, R.¹⁷ Carr, S.A.¹⁸ Lander, E.S.¹⁹ Golub, T.R.²⁰ more..

7
- 0037385522
- Insulin-like growth factor-I inhibits progesterone receptor expression in breast cancer cells via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway: Progesterone receptor as a potential indicator of growth factor activity in breast cancer
- DOI 10.1210/me.2002-0318
- Cui X, Zhang P, Deng W et al. Insulin-like growth factor-I inhibits progesterone receptor expression in breast cancer cells via the phosphatidylinositol 3-kinase/Akt/ mammalian target of rapamycin pathway: progesterone receptor as a potential indicator of growth factor activity in breast cancer. Mol. Endocrinol. 17(4), 575-588 (2003). (Pubitemid 36403572)
- (2003) Molecular Endocrinology , vol.17 , Issue.4 , pp. 575-588
- Cui, X.¹ Zhang, P.² Deng, W.³ Oesterreich, S.⁴ Lu., Y.⁵ Mills, G.B.⁶ Lee, A.V.⁷

8
- 78650735473
- The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models
- Shi L, Campbell G, Jones WD et al. The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models. Nat. Biotechnol. 28(8), 827-838 (2010).
- (2010) Nat. Biotechnol. , vol.28 , Issue.8 , pp. 827-838
- Shi, L.¹ Campbell, G.² Jones, W.D.³

9
- 33846978784
- Critical review of published microarray studies for cancer outcome and guidelines on statistical analysis and reporting
- Dupuy A, Simon RM. Critical review of published microarray studies for cancer outcome and guidelines on statistical analysis and reporting. J. Natl Cancer Inst. 99(2), 147-157 (2007).
- (2007) J. Natl Cancer Inst. , vol.99 , Issue.2 , pp. 147-157
- Dupuy, A.¹ Simon, R.M.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.